Total Payments
$4,324
2024 Payments
$1,266
Companies
41
Transactions
210
Medicare Patients
10,060
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$4,024 (93.1%)
Education$300.01 (6.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,024 | 204 | 93.1% |
| Education | $300.01 | 6 | 6.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mylan Specialty L.P. | $520.65 | 27 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $380.58 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $303.62 | 17 | $0 (2023) |
| GlaxoSmithKline, LLC. | $299.56 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $295.41 | 12 | $0 (2024) |
| 3B Medical, Inc. | $258.09 | 1 | $0 (2023) |
| UCB, Inc. | $209.05 | 12 | $0 (2024) |
| Biogen, Inc. | $166.37 | 8 | $0 (2024) |
| INOGEN, INC. | $153.85 | 7 | $0 (2024) |
| SK Life Science, Inc. | $147.17 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,266 | 63 | UCB, Inc. ($153.96) |
| 2023 | $1,300 | 56 | 3B Medical, Inc. ($258.09) |
| 2022 | $860.16 | 42 | Harmony Biosciences LLC ($194.75) |
| 2021 | $253.31 | 15 | Mylan Specialty L.P. ($92.71) |
| 2020 | $154.14 | 8 | GlaxoSmithKline, LLC. ($39.41) |
| 2019 | $228.30 | 8 | Insmed, Inc. ($74.99) |
| 2018 | $40.60 | 3 | Grifols USA, LLC ($16.20) |
| 2017 | $221.10 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($104.84) |
All Payment Transactions
210 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: EPILEPSY | ||||||
| 12/12/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/11/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Neurology | ||||||
| 12/03/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/27/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $42.69 | General |
| Category: Narcoplepsy | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Philips North America LLC | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $15.56 | General |
| Category: Medical Device | ||||||
| 11/19/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $8.00 | General |
| Category: Narcoplepsy | ||||||
| 11/19/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $3.22 | General |
| Category: Narcoplepsy | ||||||
| 11/13/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/05/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Neurology | ||||||
| 11/02/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $19.47 | General |
| Category: Narcoplepsy | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/10/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: NEUROLOGY | ||||||
| 10/08/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Neurology | ||||||
| 10/08/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $3.99 | General |
| Category: Narcoplepsy | ||||||
| 10/08/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: Neurology | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Neurology | ||||||
| 09/06/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Rare Disease | ||||||
| 09/04/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: EPILEPSY | ||||||
| 08/07/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Neurology | ||||||
| 08/06/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Neurology | ||||||
| 07/31/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $25.03 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,337 | 5,217 | $894,065 | $417,487 |
| 2022 | 20 | 2,579 | 5,790 | $909,080 | $477,571 |
| 2021 | 18 | 2,564 | 5,127 | $787,720 | $439,915 |
| 2020 | 20 | 2,580 | 4,537 | $666,843 | $364,896 |
Total Patients
10,060
Total Services
20,671
Medicare Billing
$1.7M
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 265 | 2,133 | $426,600 | $203,473 | 47.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 274 | 349 | $94,230 | $47,559 | 50.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 179 | 709 | $109,895 | $45,281 | 41.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 230 | 385 | $77,000 | $37,774 | 49.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 133 | 206 | $29,870 | $19,576 | 65.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 33 | 83 | $29,050 | $14,358 | 49.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 196 | 199 | $19,900 | $8,770 | 44.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 221 | 250 | $25,000 | $7,543 | 30.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 196 | 196 | $19,600 | $6,628 | 33.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 44 | $12,100 | $6,300 | 52.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 170 | 197 | $9,850 | $5,269 | 53.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $8,170 | $4,815 | 58.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 112 | 129 | $12,900 | $3,373 | 26.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $4,800 | $2,574 | 53.6% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 126 | 158 | $3,160 | $2,125 | 67.2% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 33 | 33 | $6,100 | $1,071 | 17.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 30 | 42 | $840.00 | $630.42 | 75.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 20 | 20 | $2,000 | $146.34 | 7.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 19 | 19 | $1,900 | $127.44 | 6.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 11 | 11 | $1,100 | $94.70 | 8.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 376 | 2,452 | $385,150 | $207,098 | 53.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 383 | 479 | $129,330 | $76,807 | 59.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 247 | 861 | $120,195 | $50,683 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 251 | 375 | $58,115 | $34,853 | 60.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 206 | 321 | $46,545 | $33,194 | 71.3% |
About Dr. Ravinder Gandhi, M.D
Dr. Ravinder Gandhi, M.D is a Pulmonary Disease healthcare provider based in Wyandotte, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003995689.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ravinder Gandhi, M.D has received a total of $4,324 in payments from pharmaceutical and medical device companies, with $1,266 received in 2024. These payments were reported across 210 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($4,024).
As a Medicare-enrolled provider, Gandhi has provided services to 10,060 Medicare beneficiaries, totaling 20,671 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Wyandotte, MI
- Active Since 11/03/2006
- Last Updated 10/29/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003995689
Products in Payments
- DUPIXENT (Biological) $376.49
- Yupelri (Drug) $300.80
- LUNA (Device) $258.09
- Wakix (Drug) $223.89
- YUPELRI (Drug) $200.39
- Nayzilam (Drug) $177.12
- WAKIX (Drug) $156.69
- TEZSPIRE (Biological) $146.75
- NUCALA (Biological) $134.54
- TRELEGY ELLIPTA (Drug) $122.65
- BREZTRI (Drug) $118.68
- Arikayce (Drug) $106.27
- OPSUMIT (Drug) $102.10
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $92.95
- VALTOCO (Drug) $83.00
- TYSABRI (Biological) $82.52
- AVONEX (Biological) $66.04
- Enspryng (Biological) $63.45
- XYWAV (Drug) $61.03
- ULTOMIRIS (Biological) $59.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.